0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Molecular Diagnostic Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-14N3176
Home | Market Reports | Health| Medical Devices & Equipment
Global Molecular Diagnostic Products Market Insights Forecast to 2028
BUY CHAPTERS

Molecular Diagnostic Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-14N3176
Report
October 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Molecular Diagnostic Products - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Molecular Diagnostic Products - Market

Molecular Diagnostic Products - Market

Molecular Diagnostic Products are medical tools and tests that identify and analyze genetic and molecular markers in biological samples. These products enable the detection of specific DNA, RNA, or protein sequences associated with diseases or conditions. Molecular diagnostic products are used in fields such as genetics, oncology, infectious diseases, and personalized medicine.
The global market for Molecular Diagnostic Products was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostic Products, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Molecular Diagnostic Products by region & country, by Type, and by Application.
The Molecular Diagnostic Products market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostic Products.
Market Segmentation

Scope of Molecular Diagnostic Products - Market Report

Report Metric Details
Report Name Molecular Diagnostic Products - Market
CAGR 5%
Segment by Type:
Segment by Application
  • Clinics
  • Hospitals
  • Laboratory
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, ThermoFisher, Roche, DAAN Gene, BGI Group, Agilent Technologies, QIAGEN, Macrogen, ELITech Group, Analytik Jena, Bio-Rad, Promega, Texas BioGene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Molecular Diagnostic Products manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Molecular Diagnostic Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Molecular Diagnostic Products in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Molecular Diagnostic Products - Market report?

Ans: The main players in the Molecular Diagnostic Products - Market are Illumina, ThermoFisher, Roche, DAAN Gene, BGI Group, Agilent Technologies, QIAGEN, Macrogen, ELITech Group, Analytik Jena, Bio-Rad, Promega, Texas BioGene

What are the Application segmentation covered in the Molecular Diagnostic Products - Market report?

Ans: The Applications covered in the Molecular Diagnostic Products - Market report are Clinics, Hospitals, Laboratory, Others

What are the Type segmentation covered in the Molecular Diagnostic Products - Market report?

Ans: The Types covered in the Molecular Diagnostic Products - Market report are Molecular Diagnostic Reagents, Molecular Diagnostic Instruments

Recommended Reports

Molecular Diagnostics

Cancer Diagnostics

Rapid & Point-of-Care Diagnostics

1 Market Overview
1.1 Molecular Diagnostic Products Product Introduction
1.2 Global Molecular Diagnostic Products Market Size Forecast
1.3 Molecular Diagnostic Products Market Trends & Drivers
1.3.1 Molecular Diagnostic Products Industry Trends
1.3.2 Molecular Diagnostic Products Market Drivers & Opportunity
1.3.3 Molecular Diagnostic Products Market Challenges
1.3.4 Molecular Diagnostic Products Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Molecular Diagnostic Products Players Revenue Ranking (2023)
2.2 Global Molecular Diagnostic Products Revenue by Company (2019-2024)
2.3 Key Companies Molecular Diagnostic Products Manufacturing Base Distribution and Headquarters
2.4 Key Companies Molecular Diagnostic Products Product Offered
2.5 Key Companies Time to Begin Mass Production of Molecular Diagnostic Products
2.6 Molecular Diagnostic Products Market Competitive Analysis
2.6.1 Molecular Diagnostic Products Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Molecular Diagnostic Products Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostic Products as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Molecular Diagnostic Reagents
3.1.2 Molecular Diagnostic Instruments
3.2 Global Molecular Diagnostic Products Sales Value by Type
3.2.1 Global Molecular Diagnostic Products Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Molecular Diagnostic Products Sales Value, by Type (2019-2030)
3.2.3 Global Molecular Diagnostic Products Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinics
4.1.2 Hospitals
4.1.3 Laboratory
4.1.4 Others
4.2 Global Molecular Diagnostic Products Sales Value by Application
4.2.1 Global Molecular Diagnostic Products Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Molecular Diagnostic Products Sales Value, by Application (2019-2030)
4.2.3 Global Molecular Diagnostic Products Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Molecular Diagnostic Products Sales Value by Region
5.1.1 Global Molecular Diagnostic Products Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Molecular Diagnostic Products Sales Value by Region (2019-2024)
5.1.3 Global Molecular Diagnostic Products Sales Value by Region (2025-2030)
5.1.4 Global Molecular Diagnostic Products Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Molecular Diagnostic Products Sales Value, 2019-2030
5.2.2 North America Molecular Diagnostic Products Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Molecular Diagnostic Products Sales Value, 2019-2030
5.3.2 Europe Molecular Diagnostic Products Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Molecular Diagnostic Products Sales Value, 2019-2030
5.4.2 Asia Pacific Molecular Diagnostic Products Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Molecular Diagnostic Products Sales Value, 2019-2030
5.5.2 South America Molecular Diagnostic Products Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Molecular Diagnostic Products Sales Value, 2019-2030
5.6.2 Middle East & Africa Molecular Diagnostic Products Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Molecular Diagnostic Products Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Molecular Diagnostic Products Sales Value
6.3 United States
6.3.1 United States Molecular Diagnostic Products Sales Value, 2019-2030
6.3.2 United States Molecular Diagnostic Products Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Molecular Diagnostic Products Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Molecular Diagnostic Products Sales Value, 2019-2030
6.4.2 Europe Molecular Diagnostic Products Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Molecular Diagnostic Products Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Molecular Diagnostic Products Sales Value, 2019-2030
6.5.2 China Molecular Diagnostic Products Sales Value by Type (%), 2023 VS 2030
6.5.3 China Molecular Diagnostic Products Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Molecular Diagnostic Products Sales Value, 2019-2030
6.6.2 Japan Molecular Diagnostic Products Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Molecular Diagnostic Products Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Molecular Diagnostic Products Sales Value, 2019-2030
6.7.2 South Korea Molecular Diagnostic Products Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Molecular Diagnostic Products Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Molecular Diagnostic Products Sales Value, 2019-2030
6.8.2 Southeast Asia Molecular Diagnostic Products Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Molecular Diagnostic Products Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Molecular Diagnostic Products Sales Value, 2019-2030
6.9.2 India Molecular Diagnostic Products Sales Value by Type (%), 2023 VS 2030
6.9.3 India Molecular Diagnostic Products Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Illumina
7.1.1 Illumina Profile
7.1.2 Illumina Main Business
7.1.3 Illumina Molecular Diagnostic Products Products, Services and Solutions
7.1.4 Illumina Molecular Diagnostic Products Revenue (US$ Million) & (2019-2024)
7.1.5 Illumina Recent Developments
7.2 ThermoFisher
7.2.1 ThermoFisher Profile
7.2.2 ThermoFisher Main Business
7.2.3 ThermoFisher Molecular Diagnostic Products Products, Services and Solutions
7.2.4 ThermoFisher Molecular Diagnostic Products Revenue (US$ Million) & (2019-2024)
7.2.5 ThermoFisher Recent Developments
7.3 Roche
7.3.1 Roche Profile
7.3.2 Roche Main Business
7.3.3 Roche Molecular Diagnostic Products Products, Services and Solutions
7.3.4 Roche Molecular Diagnostic Products Revenue (US$ Million) & (2019-2024)
7.3.5 DAAN Gene Recent Developments
7.4 DAAN Gene
7.4.1 DAAN Gene Profile
7.4.2 DAAN Gene Main Business
7.4.3 DAAN Gene Molecular Diagnostic Products Products, Services and Solutions
7.4.4 DAAN Gene Molecular Diagnostic Products Revenue (US$ Million) & (2019-2024)
7.4.5 DAAN Gene Recent Developments
7.5 BGI Group
7.5.1 BGI Group Profile
7.5.2 BGI Group Main Business
7.5.3 BGI Group Molecular Diagnostic Products Products, Services and Solutions
7.5.4 BGI Group Molecular Diagnostic Products Revenue (US$ Million) & (2019-2024)
7.5.5 BGI Group Recent Developments
7.6 Agilent Technologies
7.6.1 Agilent Technologies Profile
7.6.2 Agilent Technologies Main Business
7.6.3 Agilent Technologies Molecular Diagnostic Products Products, Services and Solutions
7.6.4 Agilent Technologies Molecular Diagnostic Products Revenue (US$ Million) & (2019-2024)
7.6.5 Agilent Technologies Recent Developments
7.7 QIAGEN
7.7.1 QIAGEN Profile
7.7.2 QIAGEN Main Business
7.7.3 QIAGEN Molecular Diagnostic Products Products, Services and Solutions
7.7.4 QIAGEN Molecular Diagnostic Products Revenue (US$ Million) & (2019-2024)
7.7.5 QIAGEN Recent Developments
7.8 Macrogen
7.8.1 Macrogen Profile
7.8.2 Macrogen Main Business
7.8.3 Macrogen Molecular Diagnostic Products Products, Services and Solutions
7.8.4 Macrogen Molecular Diagnostic Products Revenue (US$ Million) & (2019-2024)
7.8.5 Macrogen Recent Developments
7.9 ELITech Group
7.9.1 ELITech Group Profile
7.9.2 ELITech Group Main Business
7.9.3 ELITech Group Molecular Diagnostic Products Products, Services and Solutions
7.9.4 ELITech Group Molecular Diagnostic Products Revenue (US$ Million) & (2019-2024)
7.9.5 ELITech Group Recent Developments
7.10 Analytik Jena
7.10.1 Analytik Jena Profile
7.10.2 Analytik Jena Main Business
7.10.3 Analytik Jena Molecular Diagnostic Products Products, Services and Solutions
7.10.4 Analytik Jena Molecular Diagnostic Products Revenue (US$ Million) & (2019-2024)
7.10.5 Analytik Jena Recent Developments
7.11 Bio-Rad
7.11.1 Bio-Rad Profile
7.11.2 Bio-Rad Main Business
7.11.3 Bio-Rad Molecular Diagnostic Products Products, Services and Solutions
7.11.4 Bio-Rad Molecular Diagnostic Products Revenue (US$ Million) & (2019-2024)
7.11.5 Bio-Rad Recent Developments
7.12 Promega
7.12.1 Promega Profile
7.12.2 Promega Main Business
7.12.3 Promega Molecular Diagnostic Products Products, Services and Solutions
7.12.4 Promega Molecular Diagnostic Products Revenue (US$ Million) & (2019-2024)
7.12.5 Promega Recent Developments
7.13 Texas BioGene
7.13.1 Texas BioGene Profile
7.13.2 Texas BioGene Main Business
7.13.3 Texas BioGene Molecular Diagnostic Products Products, Services and Solutions
7.13.4 Texas BioGene Molecular Diagnostic Products Revenue (US$ Million) & (2019-2024)
7.13.5 Texas BioGene Recent Developments
8 Industry Chain Analysis
8.1 Molecular Diagnostic Products Industrial Chain
8.2 Molecular Diagnostic Products Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Molecular Diagnostic Products Sales Model
8.5.2 Sales Channel
8.5.3 Molecular Diagnostic Products Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Molecular Diagnostic Products Market Trends
    Table 2. Molecular Diagnostic Products Market Drivers & Opportunity
    Table 3. Molecular Diagnostic Products Market Challenges
    Table 4. Molecular Diagnostic Products Market Restraints
    Table 5. Global Molecular Diagnostic Products Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Molecular Diagnostic Products Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Molecular Diagnostic Products Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Molecular Diagnostic Products Product Type
    Table 9. Key Companies Time to Begin Mass Production of Molecular Diagnostic Products
    Table 10. Global Molecular Diagnostic Products Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostic Products as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Molecular Diagnostic Products Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Molecular Diagnostic Products Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Molecular Diagnostic Products Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Molecular Diagnostic Products Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Molecular Diagnostic Products Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Molecular Diagnostic Products Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Molecular Diagnostic Products Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Molecular Diagnostic Products Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Molecular Diagnostic Products Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Molecular Diagnostic Products Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Molecular Diagnostic Products Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Molecular Diagnostic Products Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Molecular Diagnostic Products Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Molecular Diagnostic Products Sales Value by Region (2019-2024) & (%)
    Table 27. Global Molecular Diagnostic Products Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Molecular Diagnostic Products Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Molecular Diagnostic Products Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Molecular Diagnostic Products Sales Value, (2025-2030) & (US$ Million)
    Table 31. Illumina Basic Information List
    Table 32. Illumina Description and Business Overview
    Table 33. Illumina Molecular Diagnostic Products Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Molecular Diagnostic Products Business of Illumina (2019-2024)
    Table 35. Illumina Recent Developments
    Table 36. ThermoFisher Basic Information List
    Table 37. ThermoFisher Description and Business Overview
    Table 38. ThermoFisher Molecular Diagnostic Products Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Molecular Diagnostic Products Business of ThermoFisher (2019-2024)
    Table 40. ThermoFisher Recent Developments
    Table 41. Roche Basic Information List
    Table 42. Roche Description and Business Overview
    Table 43. Roche Molecular Diagnostic Products Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Molecular Diagnostic Products Business of Roche (2019-2024)
    Table 45. Roche Recent Developments
    Table 46. DAAN Gene Basic Information List
    Table 47. DAAN Gene Description and Business Overview
    Table 48. DAAN Gene Molecular Diagnostic Products Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Molecular Diagnostic Products Business of DAAN Gene (2019-2024)
    Table 50. DAAN Gene Recent Developments
    Table 51. BGI Group Basic Information List
    Table 52. BGI Group Description and Business Overview
    Table 53. BGI Group Molecular Diagnostic Products Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Molecular Diagnostic Products Business of BGI Group (2019-2024)
    Table 55. BGI Group Recent Developments
    Table 56. Agilent Technologies Basic Information List
    Table 57. Agilent Technologies Description and Business Overview
    Table 58. Agilent Technologies Molecular Diagnostic Products Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Molecular Diagnostic Products Business of Agilent Technologies (2019-2024)
    Table 60. Agilent Technologies Recent Developments
    Table 61. QIAGEN Basic Information List
    Table 62. QIAGEN Description and Business Overview
    Table 63. QIAGEN Molecular Diagnostic Products Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Molecular Diagnostic Products Business of QIAGEN (2019-2024)
    Table 65. QIAGEN Recent Developments
    Table 66. Macrogen Basic Information List
    Table 67. Macrogen Description and Business Overview
    Table 68. Macrogen Molecular Diagnostic Products Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Molecular Diagnostic Products Business of Macrogen (2019-2024)
    Table 70. Macrogen Recent Developments
    Table 71. ELITech Group Basic Information List
    Table 72. ELITech Group Description and Business Overview
    Table 73. ELITech Group Molecular Diagnostic Products Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Molecular Diagnostic Products Business of ELITech Group (2019-2024)
    Table 75. ELITech Group Recent Developments
    Table 76. Analytik Jena Basic Information List
    Table 77. Analytik Jena Description and Business Overview
    Table 78. Analytik Jena Molecular Diagnostic Products Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Molecular Diagnostic Products Business of Analytik Jena (2019-2024)
    Table 80. Analytik Jena Recent Developments
    Table 81. Bio-Rad Basic Information List
    Table 82. Bio-Rad Description and Business Overview
    Table 83. Bio-Rad Molecular Diagnostic Products Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Molecular Diagnostic Products Business of Bio-Rad (2019-2024)
    Table 85. Bio-Rad Recent Developments
    Table 86. Promega Basic Information List
    Table 87. Promega Description and Business Overview
    Table 88. Promega Molecular Diagnostic Products Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Molecular Diagnostic Products Business of Promega (2019-2024)
    Table 90. Promega Recent Developments
    Table 91. Texas BioGene Basic Information List
    Table 92. Texas BioGene Description and Business Overview
    Table 93. Texas BioGene Molecular Diagnostic Products Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Molecular Diagnostic Products Business of Texas BioGene (2019-2024)
    Table 95. Texas BioGene Recent Developments
    Table 96. Key Raw Materials Lists
    Table 97. Raw Materials Key Suppliers Lists
    Table 98. Molecular Diagnostic Products Downstream Customers
    Table 99. Molecular Diagnostic Products Distributors List
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
    Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Molecular Diagnostic Products Product Picture
    Figure 2. Global Molecular Diagnostic Products Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Molecular Diagnostic Products Sales Value (2019-2030) & (US$ Million)
    Figure 4. Molecular Diagnostic Products Report Years Considered
    Figure 5. Global Molecular Diagnostic Products Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Molecular Diagnostic Products Revenue in 2023
    Figure 7. Molecular Diagnostic Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Molecular Diagnostic Reagents Picture
    Figure 9. Molecular Diagnostic Instruments Picture
    Figure 10. Global Molecular Diagnostic Products Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Molecular Diagnostic Products Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Clinics
    Figure 13. Product Picture of Hospitals
    Figure 14. Product Picture of Laboratory
    Figure 15. Product Picture of Others
    Figure 16. Global Molecular Diagnostic Products Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Molecular Diagnostic Products Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Molecular Diagnostic Products Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Molecular Diagnostic Products Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Molecular Diagnostic Products Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Molecular Diagnostic Products Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Molecular Diagnostic Products Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Molecular Diagnostic Products Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Molecular Diagnostic Products Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Molecular Diagnostic Products Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Molecular Diagnostic Products Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Molecular Diagnostic Products Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Molecular Diagnostic Products Sales Value (%), (2019-2030)
    Figure 29. United States Molecular Diagnostic Products Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Molecular Diagnostic Products Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Molecular Diagnostic Products Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Molecular Diagnostic Products Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Molecular Diagnostic Products Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Molecular Diagnostic Products Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Molecular Diagnostic Products Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Molecular Diagnostic Products Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Molecular Diagnostic Products Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Molecular Diagnostic Products Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Molecular Diagnostic Products Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Molecular Diagnostic Products Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Molecular Diagnostic Products Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Molecular Diagnostic Products Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Molecular Diagnostic Products Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Molecular Diagnostic Products Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Molecular Diagnostic Products Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Molecular Diagnostic Products Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Molecular Diagnostic Products Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Molecular Diagnostic Products Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Molecular Diagnostic Products Sales Value by Application (%), 2023 VS 2030
    Figure 50. Molecular Diagnostic Products Industrial Chain
    Figure 51. Molecular Diagnostic Products Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart